Click for best price
Prostate Cancer Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 6493 million
|
Forecast Market size by 2029 |
US$ 9906.2 million
|
| Growth Rate |
CAGR of 6.2% |
Number of Pages |
128 Pages |
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Drugs. This report contains market size and forecasts of Prostate Cancer Drugs in global, including the following market information:
Global Prostate Cancer Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prostate Cancer Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Prostate Cancer Drugs companies in 2022 (%)
The global Prostate Cancer Drugs market was valued at US$ 6493 million in 2022 and is projected to reach US$ 9906.2 million by 2029, at a CAGR of 6.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hormonal Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Drugs include AbbVie, Astellas Pharma, Astra Zeneca, Johnson & Johnson, Sanofi, GlaxoSmithKline, Merck Group, Novartis and Amgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Prostate Cancer Drugs Market Segment Percentages, by Type, 2022 (%)
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Global Prostate Cancer Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Prostate Cancer Drugs Market Segment Percentages, by Application, 2022 (%)
Clinics
Hospitals
Others
Global Prostate Cancer Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Prostate Cancer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prostate Cancer Drugs revenues share in global market, 2022 (%)
Key companies Prostate Cancer Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Prostate Cancer Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Astellas Pharma
Astra Zeneca
Johnson & Johnson
Sanofi
GlaxoSmithKline
Merck Group
Novartis
Amgen
Bayer HealthCare
Ferring Pharmaceutical
Janssen Pharmaceuticals
Endo Pharmaceuticals
BMS
Takeda Pharmaceuticals
Northwest Biotherapeutics
Teva Pharmaceutical
Boehringer Ingelheim
Foresee Pharmaceuticals
Tokai Pharmaceuticals
Spectrum Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Drugs, market overview.
Chapter 2: Global Prostate Cancer Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Prostate Cancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prostate Cancer Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Drugs Market, Global Outlook and Forecast 2023-2035 |
| Market size in 2022 |
US$ 6493 million
|
| Forecast Market size by 2029 |
US$ 9906.2 million
|
| Growth Rate |
CAGR of 6.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
128 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Drugs Overall Market Size
2.1 Global Prostate Cancer Drugs Market Size: 2022 VS 2035
2.2 Global Prostate Cancer Drugs Revenue, Prospects & Forecasts: 2018-2035
2.3 Global Prostate Cancer Drugs Sales: 2018-2035
3 Company Landscape
3.1 Top Prostate Cancer Drugs Players in Global Market
3.2 Top Global Prostate Cancer Drugs Companies Ranked by Revenue
3.3 Global Prostate Cancer Drugs Revenue by Companies
3.4 Global Prostate Cancer Drugs Sales by Companies
3.5 Global Prostate Cancer Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prostate Cancer Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prostate Cancer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prostate Cancer Drugs Players in Global Market
3.8.1 List of Global Tier 1 Prostate Cancer Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Prostate Cancer Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Drugs Market Size Markets, 2022 & 2035
4.1.2 Hormonal Therapy
4.1.3 Chemotherapy
4.1.4 Immunotherapy
4.1.5 Targeted Therapy
4.2 By Type - Global Prostate Cancer Drugs Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Drugs Revenue, 2024-2035
4.2.3 By Type - Global Prostate Cancer Drugs Revenue Market Share, 2018-2035
4.3 By Type - Global Prostate Cancer Drugs Sales & Forecasts
4.3.1 By Type - Global Prostate Cancer Drugs Sales, 2018-2023
4.3.2 By Type - Global Prostate Cancer Drugs Sales, 2024-2035
4.3.3 By Type - Global Prostate Cancer Drugs Sales Market Share, 2018-2035
4.4 By Type - Global Prostate Cancer Drugs Price (Manufacturers Selling Prices), 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Drugs Market Size, 2022 & 2035
5.1.2 Clinics
5.1.3 Hospitals
5.1.4 Others
5.2 By Application - Global Prostate Cancer Drugs Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Drugs Revenue, 2024-2035
5.2.3 By Application - Global Prostate Cancer Drugs Revenue Market Share, 2018-2035
5.3 By Application - Global Prostate Cancer Drugs Sales & Forecasts
5.3.1 By Application - Global Prostate Cancer Drugs Sales, 2018-2023
5.3.2 By Application - Global Prostate Cancer Drugs Sales, 2024-2035
5.3.3 By Application - Global Prostate Cancer Drugs Sales Market Share, 2018-2035
5.4 By Application - Global Prostate Cancer Drugs Price (Manufacturers Selling Prices), 2018-2035
6 Sights by Region
6.1 By Region - Global Prostate Cancer Drugs Market Size, 2022 & 2035
6.2 By Region - Global Prostate Cancer Drugs Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Drugs Revenue, 2024-2035
6.2.3 By Region - Global Prostate Cancer Drugs Revenue Market Share, 2018-2035
6.3 By Region - Global Prostate Cancer Drugs Sales & Forecasts
6.3.1 By Region - Global Prostate Cancer Drugs Sales, 2018-2023
6.3.2 By Region - Global Prostate Cancer Drugs Sales, 2024-2035
6.3.3 By Region - Global Prostate Cancer Drugs Sales Market Share, 2018-2035
6.4 North America
6.4.1 By Country - North America Prostate Cancer Drugs Revenue, 2018-2035
6.4.2 By Country - North America Prostate Cancer Drugs Sales, 2018-2035
6.4.3 US Prostate Cancer Drugs Market Size, 2018-2035
6.4.4 Canada Prostate Cancer Drugs Market Size, 2018-2035
6.4.5 Mexico Prostate Cancer Drugs Market Size, 2018-2035
6.5 Europe
6.5.1 By Country - Europe Prostate Cancer Drugs Revenue, 2018-2035
6.5.2 By Country - Europe Prostate Cancer Drugs Sales, 2018-2035
6.5.3 Germany Prostate Cancer Drugs Market Size, 2018-2035
6.5.4 France Prostate Cancer Drugs Market Size, 2018-2035
6.5.5 U.K. Prostate Cancer Drugs Market Size, 2018-2035
6.5.6 Italy Prostate Cancer Drugs Market Size, 2018-2035
6.5.7 Russia Prostate Cancer Drugs Market Size, 2018-2035
6.5.8 Nordic Countries Prostate Cancer Drugs Market Size, 2018-2035
6.5.9 Benelux Prostate Cancer Drugs Market Size, 2018-2035
6.6 Asia
6.6.1 By Region - Asia Prostate Cancer Drugs Revenue, 2018-2035
6.6.2 By Region - Asia Prostate Cancer Drugs Sales, 2018-2035
6.6.3 China Prostate Cancer Drugs Market Size, 2018-2035
6.6.4 Japan Prostate Cancer Drugs Market Size, 2018-2035
6.6.5 South Korea Prostate Cancer Drugs Market Size, 2018-2035
6.6.6 Southeast Asia Prostate Cancer Drugs Market Size, 2018-2035
6.6.7 India Prostate Cancer Drugs Market Size, 2018-2035
6.7 South America
6.7.1 By Country - South America Prostate Cancer Drugs Revenue, 2018-2035
6.7.2 By Country - South America Prostate Cancer Drugs Sales, 2018-2035
6.7.3 Brazil Prostate Cancer Drugs Market Size, 2018-2035
6.7.4 Argentina Prostate Cancer Drugs Market Size, 2018-2035
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prostate Cancer Drugs Revenue, 2018-2035
6.8.2 By Country - Middle East & Africa Prostate Cancer Drugs Sales, 2018-2035
6.8.3 Turkey Prostate Cancer Drugs Market Size, 2018-2035
6.8.4 Israel Prostate Cancer Drugs Market Size, 2018-2035
6.8.5 Saudi Arabia Prostate Cancer Drugs Market Size, 2018-2035
6.8.6 UAE Prostate Cancer Drugs Market Size, 2018-2035
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Prostate Cancer Drugs Major Product Offerings
7.1.4 AbbVie Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Prostate Cancer Drugs Major Product Offerings
7.2.4 Astellas Pharma Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 Astra Zeneca
7.3.1 Astra Zeneca Company Summary
7.3.2 Astra Zeneca Business Overview
7.3.3 Astra Zeneca Prostate Cancer Drugs Major Product Offerings
7.3.4 Astra Zeneca Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Astra Zeneca Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Prostate Cancer Drugs Major Product Offerings
7.4.4 Johnson & Johnson Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Prostate Cancer Drugs Major Product Offerings
7.5.4 Sanofi Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Prostate Cancer Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Merck Group
7.7.1 Merck Group Company Summary
7.7.2 Merck Group Business Overview
7.7.3 Merck Group Prostate Cancer Drugs Major Product Offerings
7.7.4 Merck Group Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Merck Group Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Prostate Cancer Drugs Major Product Offerings
7.8.4 Novartis Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Prostate Cancer Drugs Major Product Offerings
7.9.4 Amgen Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Bayer HealthCare
7.10.1 Bayer HealthCare Company Summary
7.10.2 Bayer HealthCare Business Overview
7.10.3 Bayer HealthCare Prostate Cancer Drugs Major Product Offerings
7.10.4 Bayer HealthCare Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Bayer HealthCare Key News & Latest Developments
7.11 Ferring Pharmaceutical
7.11.1 Ferring Pharmaceutical Company Summary
7.11.2 Ferring Pharmaceutical Prostate Cancer Drugs Business Overview
7.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Major Product Offerings
7.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Ferring Pharmaceutical Key News & Latest Developments
7.12 Janssen Pharmaceuticals
7.12.1 Janssen Pharmaceuticals Company Summary
7.12.2 Janssen Pharmaceuticals Prostate Cancer Drugs Business Overview
7.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Janssen Pharmaceuticals Key News & Latest Developments
7.13 Endo Pharmaceuticals
7.13.1 Endo Pharmaceuticals Company Summary
7.13.2 Endo Pharmaceuticals Prostate Cancer Drugs Business Overview
7.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Endo Pharmaceuticals Key News & Latest Developments
7.14 BMS
7.14.1 BMS Company Summary
7.14.2 BMS Business Overview
7.14.3 BMS Prostate Cancer Drugs Major Product Offerings
7.14.4 BMS Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.14.5 BMS Key News & Latest Developments
7.15 Takeda Pharmaceuticals
7.15.1 Takeda Pharmaceuticals Company Summary
7.15.2 Takeda Pharmaceuticals Business Overview
7.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Takeda Pharmaceuticals Key News & Latest Developments
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Company Summary
7.16.2 Northwest Biotherapeutics Business Overview
7.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Major Product Offerings
7.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Northwest Biotherapeutics Key News & Latest Developments
7.17 Teva Pharmaceutical
7.17.1 Teva Pharmaceutical Company Summary
7.17.2 Teva Pharmaceutical Business Overview
7.17.3 Teva Pharmaceutical Prostate Cancer Drugs Major Product Offerings
7.17.4 Teva Pharmaceutical Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Teva Pharmaceutical Key News & Latest Developments
7.18 Boehringer Ingelheim
7.18.1 Boehringer Ingelheim Company Summary
7.18.2 Boehringer Ingelheim Business Overview
7.18.3 Boehringer Ingelheim Prostate Cancer Drugs Major Product Offerings
7.18.4 Boehringer Ingelheim Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Boehringer Ingelheim Key News & Latest Developments
7.19 Foresee Pharmaceuticals
7.19.1 Foresee Pharmaceuticals Company Summary
7.19.2 Foresee Pharmaceuticals Business Overview
7.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Foresee Pharmaceuticals Key News & Latest Developments
7.20 Tokai Pharmaceuticals
7.20.1 Tokai Pharmaceuticals Company Summary
7.20.2 Tokai Pharmaceuticals Business Overview
7.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Tokai Pharmaceuticals Key News & Latest Developments
7.21 Spectrum Pharmaceuticals
7.21.1 Spectrum Pharmaceuticals Company Summary
7.21.2 Spectrum Pharmaceuticals Business Overview
7.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Major Product Offerings
7.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Spectrum Pharmaceuticals Key News & Latest Developments
8 Global Prostate Cancer Drugs Production Capacity, Analysis
8.1 Global Prostate Cancer Drugs Production Capacity, 2018-2035
8.2 Prostate Cancer Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Prostate Cancer Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prostate Cancer Drugs Supply Chain Analysis
10.1 Prostate Cancer Drugs Industry Value Chain
10.2 Prostate Cancer Drugs Upstream Market
10.3 Prostate Cancer Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prostate Cancer Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Prostate Cancer Drugs in Global Market
Table 2. Top Prostate Cancer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prostate Cancer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prostate Cancer Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Prostate Cancer Drugs Sales by Companies, (K MT), 2018-2023
Table 6. Global Prostate Cancer Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prostate Cancer Drugs Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Prostate Cancer Drugs Product Type
Table 9. List of Global Tier 1 Prostate Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Global Prostate Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prostate Cancer Drugs Revenue (US$, Mn), 2024-2035
Table 14. By Type - Global Prostate Cancer Drugs Sales (K MT), 2018-2023
Table 15. By Type - Global Prostate Cancer Drugs Sales (K MT), 2024-2035
Table 16. By Application ? Global Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2035
Table 17. By Application - Global Prostate Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prostate Cancer Drugs Revenue (US$, Mn), 2024-2035
Table 19. By Application - Global Prostate Cancer Drugs Sales (K MT), 2018-2023
Table 20. By Application - Global Prostate Cancer Drugs Sales (K MT), 2024-2035
Table 21. By Region ? Global Prostate Cancer Drugs Revenue, (US$, Mn), 2022 VS 2035
Table 22. By Region - Global Prostate Cancer Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prostate Cancer Drugs Revenue (US$, Mn), 2024-2035
Table 24. By Region - Global Prostate Cancer Drugs Sales (K MT), 2018-2023
Table 25. By Region - Global Prostate Cancer Drugs Sales (K MT), 2024-2035
Table 26. By Country - North America Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2035
Table 28. By Country - North America Prostate Cancer Drugs Sales, (K MT), 2018-2023
Table 29. By Country - North America Prostate Cancer Drugs Sales, (K MT), 2024-2035
Table 30. By Country - Europe Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2035
Table 32. By Country - Europe Prostate Cancer Drugs Sales, (K MT), 2018-2023
Table 33. By Country - Europe Prostate Cancer Drugs Sales, (K MT), 2024-2035
Table 34. By Region - Asia Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2035
Table 36. By Region - Asia Prostate Cancer Drugs Sales, (K MT), 2018-2023
Table 37. By Region - Asia Prostate Cancer Drugs Sales, (K MT), 2024-2035
Table 38. By Country - South America Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2035
Table 40. By Country - South America Prostate Cancer Drugs Sales, (K MT), 2018-2023
Table 41. By Country - South America Prostate Cancer Drugs Sales, (K MT), 2024-2035
Table 42. By Country - Middle East & Africa Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prostate Cancer Drugs Revenue, (US$, Mn), 2024-2035
Table 44. By Country - Middle East & Africa Prostate Cancer Drugs Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Prostate Cancer Drugs Sales, (K MT), 2024-2035
Table 46. AbbVie Company Summary
Table 47. AbbVie Prostate Cancer Drugs Product Offerings
Table 48. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. Astellas Pharma Company Summary
Table 51. Astellas Pharma Prostate Cancer Drugs Product Offerings
Table 52. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Astellas Pharma Key News & Latest Developments
Table 54. Astra Zeneca Company Summary
Table 55. Astra Zeneca Prostate Cancer Drugs Product Offerings
Table 56. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Astra Zeneca Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Prostate Cancer Drugs Product Offerings
Table 60. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Prostate Cancer Drugs Product Offerings
Table 64. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Prostate Cancer Drugs Product Offerings
Table 68. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Merck Group Company Summary
Table 71. Merck Group Prostate Cancer Drugs Product Offerings
Table 72. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Merck Group Key News & Latest Developments
Table 74. Novartis Company Summary
Table 75. Novartis Prostate Cancer Drugs Product Offerings
Table 76. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. Novartis Key News & Latest Developments
Table 78. Amgen Company Summary
Table 79. Amgen Prostate Cancer Drugs Product Offerings
Table 80. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Amgen Key News & Latest Developments
Table 82. Bayer HealthCare Company Summary
Table 83. Bayer HealthCare Prostate Cancer Drugs Product Offerings
Table 84. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Bayer HealthCare Key News & Latest Developments
Table 86. Ferring Pharmaceutical Company Summary
Table 87. Ferring Pharmaceutical Prostate Cancer Drugs Product Offerings
Table 88. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 89. Ferring Pharmaceutical Key News & Latest Developments
Table 90. Janssen Pharmaceuticals Company Summary
Table 91. Janssen Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 92. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 93. Janssen Pharmaceuticals Key News & Latest Developments
Table 94. Endo Pharmaceuticals Company Summary
Table 95. Endo Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 96. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 97. Endo Pharmaceuticals Key News & Latest Developments
Table 98. BMS Company Summary
Table 99. BMS Prostate Cancer Drugs Product Offerings
Table 100. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 101. BMS Key News & Latest Developments
Table 102. Takeda Pharmaceuticals Company Summary
Table 103. Takeda Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 104. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 105. Takeda Pharmaceuticals Key News & Latest Developments
Table 106. Northwest Biotherapeutics Company Summary
Table 107. Northwest Biotherapeutics Prostate Cancer Drugs Product Offerings
Table 108. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 109. Northwest Biotherapeutics Key News & Latest Developments
Table 110. Teva Pharmaceutical Company Summary
Table 111. Teva Pharmaceutical Prostate Cancer Drugs Product Offerings
Table 112. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 113. Teva Pharmaceutical Key News & Latest Developments
Table 114. Boehringer Ingelheim Company Summary
Table 115. Boehringer Ingelheim Prostate Cancer Drugs Product Offerings
Table 116. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 117. Boehringer Ingelheim Key News & Latest Developments
Table 118. Foresee Pharmaceuticals Company Summary
Table 119. Foresee Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 120. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 121. Foresee Pharmaceuticals Key News & Latest Developments
Table 122. Tokai Pharmaceuticals Company Summary
Table 123. Tokai Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 124. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 125. Tokai Pharmaceuticals Key News & Latest Developments
Table 126. Spectrum Pharmaceuticals Company Summary
Table 127. Spectrum Pharmaceuticals Prostate Cancer Drugs Product Offerings
Table 128. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 129. Spectrum Pharmaceuticals Key News & Latest Developments
Table 130. Prostate Cancer Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 131. Global Prostate Cancer Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 132. Global Prostate Cancer Drugs Production by Region, 2018-2023 (K MT)
Table 133. Global Prostate Cancer Drugs Production by Region, 2024-2035 (K MT)
Table 134. Prostate Cancer Drugs Market Opportunities & Trends in Global Market
Table 135. Prostate Cancer Drugs Market Drivers in Global Market
Table 136. Prostate Cancer Drugs Market Restraints in Global Market
Table 137. Prostate Cancer Drugs Raw Materials
Table 138. Prostate Cancer Drugs Raw Materials Suppliers in Global Market
Table 139. Typical Prostate Cancer Drugs Downstream
Table 140. Prostate Cancer Drugs Downstream Clients in Global Market
Table 141. Prostate Cancer Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prostate Cancer Drugs Segment by Type in 2022
Figure 2. Prostate Cancer Drugs Segment by Application in 2022
Figure 3. Global Prostate Cancer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Drugs Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Prostate Cancer Drugs Revenue, 2018-2035 (US$, Mn)
Figure 7. Prostate Cancer Drugs Sales in Global Market: 2018-2035 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Prostate Cancer Drugs Revenue in 2022
Figure 9. By Type - Global Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 10. By Type - Global Prostate Cancer Drugs Revenue Market Share, 2018-2035
Figure 11. By Type - Global Prostate Cancer Drugs Sales Market Share, 2018-2035
Figure 12. By Type - Global Prostate Cancer Drugs Price (USD/MT), 2018-2035
Figure 13. By Application - Global Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 14. By Application - Global Prostate Cancer Drugs Revenue Market Share, 2018-2035
Figure 15. By Application - Global Prostate Cancer Drugs Sales Market Share, 2018-2035
Figure 16. By Application - Global Prostate Cancer Drugs Price (USD/MT), 2018-2035
Figure 17. By Region - Global Prostate Cancer Drugs Revenue, (US$, Mn), 2022 & 2035
Figure 18. By Region - Global Prostate Cancer Drugs Revenue Market Share, 2018 VS 2022 VS 2035
Figure 19. By Region - Global Prostate Cancer Drugs Revenue Market Share, 2018-2035
Figure 20. By Region - Global Prostate Cancer Drugs Sales Market Share, 2018-2035
Figure 21. By Country - North America Prostate Cancer Drugs Revenue Market Share, 2018-2035
Figure 22. By Country - North America Prostate Cancer Drugs Sales Market Share, 2018-2035
Figure 23. US Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 24. Canada Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 25. Mexico Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 26. By Country - Europe Prostate Cancer Drugs Revenue Market Share, 2018-2035
Figure 27. By Country - Europe Prostate Cancer Drugs Sales Market Share, 2018-2035
Figure 28. Germany Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 29. France Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 30. U.K. Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 31. Italy Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 32. Russia Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 33. Nordic Countries Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 34. Benelux Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 35. By Region - Asia Prostate Cancer Drugs Revenue Market Share, 2018-2035
Figure 36. By Region - Asia Prostate Cancer Drugs Sales Market Share, 2018-2035
Figure 37. China Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 38. Japan Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 39. South Korea Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 40. Southeast Asia Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 41. India Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 42. By Country - South America Prostate Cancer Drugs Revenue Market Share, 2018-2035
Figure 43. By Country - South America Prostate Cancer Drugs Sales Market Share, 2018-2035
Figure 44. Brazil Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 45. Argentina Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 46. By Country - Middle East & Africa Prostate Cancer Drugs Revenue Market Share, 2018-2035
Figure 47. By Country - Middle East & Africa Prostate Cancer Drugs Sales Market Share, 2018-2035
Figure 48. Turkey Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 49. Israel Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 50. Saudi Arabia Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 51. UAE Prostate Cancer Drugs Revenue, (US$, Mn), 2018-2035
Figure 52. Global Prostate Cancer Drugs Production Capacity (K MT), 2018-2035
Figure 53. The Percentage of Production Prostate Cancer Drugs by Region, 2022 VS 2035
Figure 54. Prostate Cancer Drugs Industry Value Chain
Figure 55. Marketing Channels
